|
Volumn 43, Issue 10, 2006, Pages
|
Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists.
a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
IMMUNOGLOBULIN G;
INFLIXIMAB;
MONOCLONAL ANTIBODY;
TNFR FC FUSION PROTEIN;
TNFR-FC FUSION PROTEIN;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR RECEPTOR;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
COMMUNICABLE DISEASE;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG ANTAGONISM;
FEMALE;
HUMAN;
LEGIONELLA PNEUMOPHILA;
LEGIONNAIRE DISEASE;
MALE;
MIDDLE AGED;
PNEUMONIA;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
COMMUNICABLE DISEASES, EMERGING;
FEMALE;
HUMANS;
IMMUNOGLOBULIN G;
LEGIONELLA PNEUMOPHILA;
LEGIONNAIRES' DISEASE;
MALE;
MIDDLE AGED;
PNEUMONIA;
RECEPTORS, TUMOR NECROSIS FACTOR;
TUMOR NECROSIS FACTOR-ALPHA;
MLCS;
MLOWN;
|
EID: 37349105953
PISSN: None
EISSN: 15376591
Source Type: Journal
DOI: 10.1086/508538 Document Type: Article |
Times cited : (127)
|
References (0)
|